Literature DB >> 17160617

The natural history of Niemann-Pick disease type C in the UK.

J Imrie1, S Dasgupta, G T N Besley, C Harris, L Heptinstall, S Knight, M T Vanier, A H Fensom, C Ward, E Jacklin, C Whitehouse, J E Wraith.   

Abstract

Niemann-Pick disease type C (NPC) is an autosomal recessive, neurovisceral lipid storage disorder. Mutations in two genes (NPC1 and NPC2) produce indistinguishable clinical phenotypes by biochemical mechanisms that have not yet been entirely clarified. The wide spectrum of clinical presentations of NPC includes hepatic and pulmonary disease as well as a range of neuropsychiatric disorders. Late-onset disease has been increasingly recognized as the biochemical diagnosis of NPC has been more widely applied in adult neurology clinics. The clinical presentation and follow-up of 94 patients with NPC is described, 58 of whom were still alive at the time this report was prepared. The age at diagnosis ranged from the prenatal period (with hydrops fetalis) up to 51 years. This review of NPC patients in the UK confirms the phenotypic variability of this inherited lipid storage disorder reported elsewhere. Although a non-neuronopathic variant has been described, most patients in this series who survived childhood inevitably suffered neurological and in some cases neuropsychiatric deterioration. While symptomatic treatment, such as anticholinergic and antiepileptic drugs, can alleviate some aspects of the disease, there is a clear need to develop a specific treatment for this progressively debilitating neurodegenerative disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160617     DOI: 10.1007/s10545-006-0384-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; N Gazzah; M C Juge; P G Pentchev; A Revol; P Louisot
Journal:  Biochim Biophys Acta       Date:  1991-06-05

2.  Adult Niemann-Pick disease type C mimicking features of multiple sclerosis.

Authors:  A J Grau; T Brandt; M Weisbrod; R Niethammer; M Forsting; M Cantz; M T Vanier; K Harzer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

3.  Identification of novel mutations in the NPC1 gene in German patients with Niemann-Pick C disease.

Authors:  W E Kaminski; H H Klünemann; B Ibach; C Aslanidis; H E Klein; G Schmitz
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

4.  Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation.

Authors:  Y S Hsu; W L Hwu; S F Huang; M Y Lu; R L Chen; D T Lin; S S Peng; K H Lin
Journal:  Bone Marrow Transplant       Date:  1999-07       Impact factor: 5.483

5.  Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.

Authors:  D Elstein; C Hollak; J M F G Aerts; S van Weely; M Maas; T M Cox; R H Lachmann; M Hrebicek; F M Platt; T D Butters; R A Dwek; A Zimran
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 6.  Niemann-Pick disease type C.

Authors:  M T Vanier; G Millat
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

7.  Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease.

Authors:  D A Kelly; B Portmann; A P Mowat; S Sherlock; B D Lake
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

Review 8.  Structure and function of the NPC2 protein.

Authors:  Marie T Vanier; Gilles Millat
Journal:  Biochim Biophys Acta       Date:  2004-10-11

9.  Progesterone blocks cholesterol translocation from lysosomes.

Authors:  J D Butler; J Blanchette-Mackie; E Goldin; R R O'Neill; G Carstea; C F Roff; M C Patterson; S Patel; M E Comly; A Cooney
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

10.  The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C.

Authors:  M C Patterson; A M Di Bisceglie; J J Higgins; R B Abel; R Schiffmann; C C Parker; C E Argoff; R P Grewal; K Yu; P G Pentchev
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

View more
  56 in total

Review 1.  Niemann-pick disease type C: implications for sedation and anesthesia for diagnostic procedures.

Authors:  Ning Miao; Xiaowei Lu; Naomi P O'Grady; Nicole Yanjanin; Forbes D Porter; Zenaide M N Quezado
Journal:  J Child Neurol       Date:  2012-02-28       Impact factor: 1.987

Review 2.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

3.  Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance.

Authors:  David Jelinek; Veronica Millward; Amandip Birdi; Theodore P Trouard; Randall A Heidenreich; William S Garver
Journal:  Hum Mol Genet       Date:  2010-10-29       Impact factor: 6.150

4.  Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C.

Authors:  Nicole M Yanjanin; Jorge I Vélez; Andrea Gropman; Kelly King; Simona E Bianconi; Sandra K Conley; Carmen C Brewer; Beth Solomon; William J Pavan; Mauricio Arcos-Burgos; Marc C Patterson; Forbes D Porter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

5.  Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C disease.

Authors:  Mathieu Anheim; Ouhaïd Lagha-Boukbiza; Marie-Céline Fleury-Lesaunier; Maria-Paola Valenti-Hirsch; Edouard Hirsch; Hélène Gervais-Bernard; Emmanuel Broussolle; Stéphane Thobois; Marie T Vanier; Philippe Latour; Christine Tranchant
Journal:  J Neurol       Date:  2013-11-01       Impact factor: 4.849

6.  Niemann-Pick disease type C in the newborn period: a single-center experience.

Authors:  Ersin Gumus; Goknur Haliloglu; Asuman Nur Karhan; Hulya Demir; Figen Gurakan; Meral Topcu; Aysel Yuce
Journal:  Eur J Pediatr       Date:  2017-09-27       Impact factor: 3.183

7.  Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

Authors:  Niklas Mattsson; Henrik Zetterberg; Simona Bianconi; Nicole M Yanjanin; Rao Fu; Jan-Eric Månsson; Forbes D Porter; Kaj Blennow
Journal:  JIMD Rep       Date:  2011-09-28

Review 8.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

Review 9.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

10.  New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat.

Authors:  James E Wraith; Jackie Imrie
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.